CrystalGenomics

Bio & Pharma CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn

South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...

Bio & Pharma CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn

CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...